MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2026.1785268

Медицинская библиотека · Frontiers in oncology · 2026

Efficacy and safety of traditional Chinese medicine decoctions in breast cancer treatment: a network meta-analysis.

Han Haidi, Du Yanan, Li Juncai, Dong Yanjing, Zhu Jingyu, Wang Haixia

СтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

Breast cancer is the most common malignant tumor among women globally. While traditional treatments are effective, they are associated with numerous side effects. In recent years, traditional Chinese herbal decoctions have garnered attention as adjunctive therapeutic approaches. This study employs a network meta-analysis to evaluate the efficacy and safety of various Chinese herbal decoctions in breast cancer treatment.

METHODS

A systematic search was conducted across PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wan fang, and VIP databases for randomized controlled trials comparing the efficacy and safety of different Chinese herbal decoctions in breast cancer patients, up to 20 December 2025. Quality assessment was performed using the Risk of Bias 2.0 tool. Network meta-analysis was conducted using R 4.5.1.

RESULTS

A total of 68 articles involving 4,708 patients were included, meta-analysis results suggest that compared with the control group, for objective response rate YHHYT [OR = 4.76, 95%CrI (1.25, 25)] ranked first in cumulative probability (81.42%). Regarding disease control rate, BZT demonstrated an [OR = 5.77, 95%CrI (1.59, 29)] and ranked first in cumulative probability (74.66%). For CD4+/CD8+, FJHQT [MD= MD = 0.69, 95%CrI (0.2, 1.17)] achieved an 88.00% cumulative probability ranking, finally, regarding nausea and vomiting relief BZT [OR = 0.25, 95%CrI (0.1, 0.57)] ranked first in cumulative probability (75.67%).

CONCLUSIONS

This study employed a network meta-analysis to evaluate the efficacy of multiple Chinese herbal decoctions in breast cancer treatment. Results demonstrated that these decoctions exhibited significant therapeutic effects in enhancing target response rates, disease control rates, and immune function (CD4+/CD8+ ratio) among breast cancer patients, while also alleviating chemotherapy side effects such as nausea and vomiting.

SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261279914, identifier CRD420261279914.

Для цитирования: Han Haidi, Du Yanan, Li Juncai, Dong Yanjing, Zhu Jingyu, Wang Haixia. Efficacy and safety of traditional Chinese medicine decoctions in breast cancer treatment: a network meta-analysis.. Frontiers in oncology. 2026. DOI: 10.3389/fonc.2026.1785268.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.